Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia
Jazyk angličtina Země Anglie, Velká Británie Médium electronic
Typ dokumentu časopisecké články, metaanalýza, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural, práce podpořená grantem, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
Grantová podpora
UL1 TR001863
NCATS NIH HHS - United States
CA098122
NCI NIH HHS - United States
R01 CA134674
NCI NIH HHS - United States
UL1 TR001070
NCATS NIH HHS - United States
CA167552
NCI NIH HHS - United States
CA118444
NCI NIH HHS - United States
N01 PC067009
NCI NIH HHS - United States
16491
Cancer Research UK - United Kingdom
N02-PC-71105
NCI NIH HHS - United States
HHSN268201100001I
NHLBI NIH HHS - United States
R35 CA197449
NCI NIH HHS - United States
N01-RC-45035
CCR NIH HHS - United States
P30 CA016087
NCI NIH HHS - United States
HHSN261201000140C
NCI NIH HHS - United States
N01 PC067010
NCI NIH HHS - United States
R01 CA098122
NCI NIH HHS - United States
P30 CA42014
NCI NIH HHS - United States
U01 HG007033
NHGRI NIH HHS - United States
K08CA134919
NCI NIH HHS - United States
P01 CA087969
NCI NIH HHS - United States
HHSN261201000006C
NCI NIH HHS - United States
R21 CA165923
NCI NIH HHS - United States
HHSN268201100004I
NHLBI NIH HHS - United States
CA154643
NCI NIH HHS - United States
K07 CA115687
NCI NIH HHS - United States
CA098566
NCI NIH HHS - United States
CA148690
NCI NIH HHS - United States
HHSN268201100046C
NHLBI NIH HHS - United States
CIHR - Canada
P30 CA086862
NCI NIH HHS - United States
U01 CA167552
NCI NIH HHS - United States
CA87969
NCI NIH HHS - United States
N01 PC067008
NCI NIH HHS - United States
HHSN268201100003C
WHI NIH HHS - United States
R01 CA148690
NCI NIH HHS - United States
P30 ES000260
NIEHS NIH HHS - United States
CA49449
NCI NIH HHS - United States
CA92153
NCI NIH HHS - United States
P30 CA008748
NCI NIH HHS - United States
R25 CA098566
NCI NIH HHS - United States
U58 DP000807
NCCDPHP CDC HHS - United States
N01-PC-67009
NCI NIH HHS - United States
1U58 DP000807-01
NCCDPHP CDC HHS - United States
CA149445
NCI NIH HHS - United States
R01 CA154643
NCI NIH HHS - United States
R01 CA062006
NCI NIH HHS - United States
N01 PC065064
NCI NIH HHS - United States
K08 CA134919
NCI NIH HHS - United States
UL1 TR000135
NCATS NIH HHS - United States
HHSN271201100004C
NIA NIH HHS - United States
R01 CA098661
NCI NIH HHS - United States
N01 CO012400
NCI NIH HHS - United States
UM1 CA186107
NCI NIH HHS - United States
HHSN268201100002C
WHI NIH HHS - United States
P30 CA015083
NCI NIH HHS - United States
R01 CA092153
NCI NIH HHS - United States
HHSN261201000035I
NCI NIH HHS - United States
NIH CA134674
NCI NIH HHS - United States
CA165923
NCI NIH HHS - United States
Intramural NIH HHS - United States
5R01 CA69669-02
NCI NIH HHS - United States
HHSN261201000035C
NCI NIH HHS - United States
HHSN261201000034C
NCI NIH HHS - United States
R01 CA92153
NCI NIH HHS - United States
UM1 CA167552
NCI NIH HHS - United States
N01 RC037004
CCR NIH HHS - United States
P50 CA097274
NCI NIH HHS - United States
R01 CA049449
NCI NIH HHS - United States
HHSN268201100002I
NHLBI NIH HHS - United States
P30 CA016359
NCI NIH HHS - United States
P30 CA15083
NCI NIH HHS - United States
CA186107
NCI NIH HHS - United States
N01 CN045165
NCI NIH HHS - United States
U01 CA049449
NCI NIH HHS - United States
R01 CA149445
NCI NIH HHS - United States
001
World Health Organization - International
HHSN268201100001C
WHI NIH HHS - United States
HHSN261201000026C
NCI NIH HHS - United States
P50 CA97274
NCI NIH HHS - United States
HHSN268201100004C
WHI NIH HHS - United States
U01 CA118444
NCI NIH HHS - United States
P30 CA042014
NCI NIH HHS - United States
ES000260
NIEHS NIH HHS - United States
30 CA086862
NCI NIH HHS - United States
CA1046282
NCI NIH HHS - United States
PubMed
26956414
PubMed Central
PMC4786871
DOI
10.1038/ncomms10933
PII: ncomms10933
Knihovny.cz E-zdroje
- MeSH
- adaptorové proteiny signální transdukční genetika MeSH
- běloši genetika MeSH
- celogenomová asociační studie * MeSH
- chronická lymfatická leukemie genetika MeSH
- genetická predispozice k nemoci MeSH
- jednonukleotidový polymorfismus MeSH
- lidé MeSH
- membránové proteiny genetika MeSH
- protein BCL2L11 MeSH
- proteiny regulující apoptózu genetika MeSH
- proteiny T-boxu genetika MeSH
- protoonkogenní proteiny genetika MeSH
- serpiny genetika MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- metaanalýza MeSH
- práce podpořená grantem MeSH
- Research Support, N.I.H., Extramural MeSH
- Research Support, N.I.H., Intramural MeSH
- Research Support, U.S. Gov't, Non-P.H.S. MeSH
- Research Support, U.S. Gov't, P.H.S. MeSH
- Názvy látek
- adaptorové proteiny signální transdukční MeSH
- BANK1 protein, human MeSH Prohlížeč
- BCL2L11 protein, human MeSH Prohlížeč
- CSRNP1 protein, human MeSH Prohlížeč
- EOMES protein, human MeSH Prohlížeč
- membránové proteiny MeSH
- protein BCL2L11 MeSH
- proteiny regulující apoptózu MeSH
- proteiny T-boxu MeSH
- protoonkogenní proteiny MeSH
- serpin B6 MeSH Prohlížeč
- serpiny MeSH
Chronic lymphocytic leukemia (CLL) is a common lymphoid malignancy with strong heritability. To further understand the genetic susceptibility for CLL and identify common loci associated with risk, we conducted a meta-analysis of four genome-wide association studies (GWAS) composed of 3,100 cases and 7,667 controls with follow-up replication in 1,958 cases and 5,530 controls. Here we report three new loci at 3p24.1 (rs9880772, EOMES, P=2.55 × 10(-11)), 6p25.2 (rs73718779, SERPINB6, P=1.97 × 10(-8)) and 3q28 (rs9815073, LPP, P=3.62 × 10(-8)), as well as a new independent SNP at the known 2q13 locus (rs9308731, BCL2L11, P=1.00 × 10(-11)) in the combined analysis. We find suggestive evidence (P<5 × 10(-7)) for two additional new loci at 4q24 (rs10028805, BANK1, P=7.19 × 10(-8)) and 3p22.2 (rs1274963, CSRNP1, P=2.12 × 10(-7)). Pathway analyses of new and known CLL loci consistently show a strong role for apoptosis, providing further evidence for the importance of this biological pathway in CLL susceptibility.
Cancer Control Research BC Cancer Agency Vancouver British Columbia Canada V5Z1L3
Cancer Epidemiology Centre Cancer Council Victoria Melbourne Victoria 3004 Australia
Cancer Epidemiology Unit University of Oxford Oxford OX3 7LF UK
Center for Lymphoid Cancer BC Cancer Agency Vancouver British Columbia Canada V5Z1L3
Chronic Disease Prevention Unit National Institute for Health and Welfare FI 00271 Helsinki Finland
CIBER de Epidemiología y Salud Pública 08036 Barcelona Spain
CIBER Epidemiología y Salud Pública 28029 Madrid Spain
Department of Biomedical Science University of Cagliari Monserrato 09042 Cagliari Italy
Department of Biostatistics Harvard School of Public Health Boston Massachusetts 02115 USA
Department of Biostatistics University of Alabama at Birmingham Birmingham Alabama 35233 USA
Department of Biostatistics Yale School of Public Health New Haven Connecticut 06520 USA
Department of Epidemiology Harvard School of Public Health Boston Massachusetts 02115 USA
Department of Epidemiology MD Anderson Cancer Center Houston Texas 77030 USA
Department of Epidemiology Murcia Regional Health Authority E30008 Murcia Spain
Department of Health Sciences Research Mayo Clinic Rochester Minnesota 55905 USA
Department of Health Sciences University of York York YO10 5DD UK
Department of Histopathology Douglass Hanly Moir Pathology Sydney New South Wales 2113 Australia
Department of Immunology Genetics and Pathology Uppsala University 75105 Uppsala Sweden
Department of Internal Medicine Huntsman Cancer Institute Salt Lake City Utah 84112 USA
Department of Internal Medicine University of Utah School of Medicine Salt Lake City Utah 84108 USA
Department of Laboratory Medicine and Pathology Mayo Clinic Rochester Minnesota 55905 USA
Department of Medical Epidemiology and Biostatistics Karolinska Institutet 17177 Stockholm Sweden
Department of Medicine Duke University and VA Medical Centers Durham North Carolina 27710 USA
Department of Medicine Mayo Clinic Rochester Minnesota 55905 USA
Department of Medicine Memorial Sloan Kettering Cancer Center New York New York 10065 USA
Department of Medicine Stanford University School of Medicine Stanford California 94305 USA
Department of Medicine University of British Columbia Vancouver British Columbia Canada V6T1Z3
Department of Nutrition Harvard School of Public Health Boston Massachusetts 02115 USA
Department of Oncology University of Sheffield Sheffield South Yorkshire S10 1NS UK
Department of Pathology University of British Columbia Vancouver British Columbia Canada V6T1Z3
Department of Population Health New York University School of Medicine New York New York 10016 USA
Department of Statistics Dongguk University Seoul 100 715 Republic of Korea
Division of Cancer Epidemiology and Genetics National Cancer Institute Bethesda Maryland 20892 USA
Division of Cancer Etiology City of Hope Beckman Research Institute Duarte California 91030 USA
Division of Endocrinology Diabetes and Metabolism The Ohio State University Columbus Ohio 43210 USA
Division of Hematology Mayo Clinic Rochester Minnesota 55905 USA
Division of Hematology Oncology Mayo Clinic Phoenix Arizona 85054 USA
Epidemiology Research Program American Cancer Society Atlanta Georgia 30303 USA
Faculty of Medicine and Health Sciences Macquarie University Sydney New South Wales 2109 Australia
Genetic Epidemiology Group Folkhälsan Research Center FI 00250 Helsinki Finland
Genome Sciences Centre BC Cancer Agency Vancouver British Columbia Canada V5Z1L3
George E Wahlen Department of Veterans Affairs Medical Center Salt Lake City Utah 84148 USA
Human Genetics Foundation 10126 Turin Italy
Institute for Risk Assessment Sciences Utrecht University Utrecht 3508 TD The Netherlands
Interdisciplinary Department of Medicine University of Bari 70124 Bari Italy
International Agency for Research on Cancer 69372 Lyon France
Ontario Health Study Toronto Ontario Canada M5G 0A3
Perlmutter Cancer Center NYU Langone Medical Center New York New York 10016 USA
Registre des hémopathies malignes de la Gironde Institut Bergonié 33076 Bordeaux Cedex France
School of Nursing and Human Sciences Dublin City University Dublin 9 Ireland
School of Public Health Imperial College London London W2 1PG UK
Sydney School of Public Health The University of Sydney Sydney New South Wales 2006 Australia
The Tisch Cancer Institute Icahn School of Medicine at Mount Sinai New York New York 10029 USA
Zobrazit více v PubMed
Siegel R., Naishadham D. & Jemal A. Cancer statistics, 2013. CA Cancer J. Clin. 63, 11–30 (2013). PubMed
Di Bernardo M. C. PubMed
Crowther-Swanepoel D. PubMed PMC
Speedy H. E. PubMed
1000 Genomes Project Consortium. PubMed PMC
Howie B. N., Donnelly P. & Marchini J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 5, e1000529 (2009). PubMed PMC
Pearce E. L. PubMed
Fisher G. H. PubMed
Drappa J., Vaishnaw A. K., Sullivan K. E., Chu J. L. & Elkon K. B. Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity. N. Engl. J. Med. 335, 1643–1649 (1996). PubMed
Zhang S., Li T., Zhang B., Nong L. & Aozasa K. Transcription factors engaged in development of NK cells are commonly expressed in nasal NK/T-cell lymphomas. Hum. Pathol. 42, 1319–1328 (2011). PubMed
Scott F. L. PubMed
Zhou Q. & Salvesen G. S. Activation of pro-caspase-7 by serine proteases includes a non-canonical specificity. Biochem. J. 324, (Pt 2): 361–364 (1997). PubMed PMC
Aiba Y. PubMed
Kozyrev S. V. PubMed
Kozyrev S. V., Bernal-Quiros M., Alarcon-Riquelme M. E. & Castillejo-Lopez C. The dual effect of the lupus-associated polymorphism rs10516487 on PubMed PMC
Ishiguro H. PubMed
Glavic A., Molnar C., Cotoras D. & de Celis J. F. Drosophila Axud1 is involved in the control of proliferation and displays pro-apoptotic activity. Mech. Dev. 126, 184–197 (2009). PubMed
Espina J., Feijoo C. G., Solis C. & Glavic A. csrnp1a is necessary for the development of primitive hematopoiesis progenitors in zebrafish. PLoS ONE 8, e53858 (2013). PubMed PMC
Gangula N. R. & Maddika S. WD repeat protein WDR48 in complex with deubiquitinase USP12 suppresses Akt-dependent cell survival signaling by stabilizing PH domain leucine-rich repeat protein phosphatase 1 (PHLPP1). J. Biol. Chem. 288, 34545–34554 (2013). PubMed PMC
Goldin L. R., Bjorkholm M., Kristinsson S. Y., Turesson I & Landgren O. Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin's lymphomas among relatives of patients with chronic lymphocytic leukemia. Haematologica 94, 647–653 (2009). PubMed PMC
Pharoah P. D. PubMed
Dixon A. L. PubMed
Abecasis G. R., Cherny S. S., Cookson W. O. & Cardon L. R. Merlin--rapid analysis of dense genetic maps using sparse gene flow trees. Nat. Genet. 30, 97–101 (2002). PubMed
Ward L. D. & Kellis M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 40, D930–D934 (2012). PubMed PMC
Wang J., Duncan D., Shi Z. & Zhang B. WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013. Nucleic Acids Res. 41, W77–W83 (2013). PubMed PMC
Barenboim M. & Manke T. ChroMoS: an integrated web tool for SNP classification, prioritization and functional interpretation. Bioinformatics 29, 2197–2198 (2013). PubMed PMC
B-Cell NHL Subtype Risk Associated with Autoimmune Conditions and PRS
Genome-wide homozygosity and risk of four non-Hodgkin lymphoma subtypes
Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes